Decision

UK REACH authorisation for Abbott Laboratories Ltd., 14 July 2023

Decision on application for authorisation under UK REACH.

Documents

Details

Decision on an application for authorisation under UK REACH.

Substance name

4-(1,1,3,3-tetramethylbutyl) phenol, ethoxylated (4-tert-OPnEO).

Authorised use

Industrial use of 4-tert-OPnEO as a surfactant in the final use of ‘in-vitro’ Diagnostic Devices (IVDs) for clinical testing in ARCHITECT, Alinity and ABBOTT PRISM automated analyser systems.

Holder of the authorisation and authorisation number

Abbott Laboratories Ltd. (UKREACH/23/03/0).

Date of decision

14 July 2023

Updates to this page

Published 31 July 2023

Sign up for emails or print this page